Basic physiology of the growth hormone/insulin-like growth factor axis

Advances in Experimental Medicine and Biology

Volumn 567, Issue , 2005, Pages 1-25

  Frago, Laura M ^a   Chowen, Julie A ^a  

^a HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

Author keywords

Binding proteins; Growth hormone releasing hormone; Intracellular signaling; Receptor; Somatostatin

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; GROWTH HORMONE RECEPTOR; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; SOMATOMEDIN RECEPTOR;

CELL FUNCTION; GROWTH; GROWTH HORMONE RELEASE; HORMONE ACTION; HUMAN DEVELOPMENT; HYPOTHALAMUS FUNCTION; METABOLISM; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TISSUE REGENERATION; ANIMAL; HUMAN;

ANIMALS; GROWTH HORMONE; HUMANS; SOMATOMEDINS;

EID: 33644810625     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/0-387-26274-1_1     Document Type: Review

References (143)

1. H.C. Mertani and G. Morel, In situ gene expression of growth hormone (GH) receptor and GH binding protein in adult male rat tissues. Mol Cell Endocrinol, 109, 47-61 (1995).
2. S.R. Edmonson, G.A. Werther, A. Russell, D. LeRoith and C.T. Roberts Jr, Localization of growth hormone receptor/binding protein messenger ribonucleic acid (mRNA) during rat fetal development: relationship to insulin-like growth factor-I mRNA. Endocrinology, 136, 4602-4609 (1995).
3. M. Ballesteros, K.C. Leung, R.J. Ross, T.P. Iismaa, and K.K. Ho, Distribution and abundance of messenger ribonucleic acid for growth hormone receptor isoforms in human tissues. J Clin Endocrinol Metab 85, 2865-2871 (2000).
4. C.A. Bondy, H. Werner, C.T. Roberts and D. LeRoith, Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain: comparison with insulin-like growth factors I and II. Neuroscience 46, 909-923 (1992).
5. A.G. Schuller, J.W. van Neck, D.J. Lindenbergh-Kortleve, C. Groffen, I. de Jon, B.C. Zwarthoff and S.L. Drop, Gene expression of the IGF binding proteins during post-implantation embryogenesis of the mouse; comparison with the expression of IGF-I and II and their receptors in rodent and human. Adv Exp Med Biol, 343, 267-277 (1993).
6. H.M. Evans and L.A. Long, The effect of the anterior lobe of the hypophysis administered intraperitoneally upon growth and maturity and estrous cycles of the rat. Anat Record 21, 62 (1921).
7. C.H. Li and H.M. Evans, The isolation of pituitary growth hormone. Science, 99, 183-185 (1944).
8. W.L. Miller and N.L. Eberhardt, Structure and evolution of the growth hormone gene family. Endocr Rev, 4, 97-130 (1983).
9. P.H. Seeburg, J. Shine, J.A. Martial, J.D. Baxter and H.M. Goodman, Nucleotide sequence and amplification in bacteria of the structural gene for rat growth hormone. Nature, 270, 486-494 (1977).
10. D. Owerbach, W.J. Rutter, J.A. Martial, J.D. Baxter and T.B. Shows, Genes for growth hormone, chorionic somatomammotropin and growth hormone-like gene on chromosome 17 in humans. Science, 209, 289-294 (1980).
11. E.Y. Chen, Y.C. Liao, D.H. Smith, H.A. Barrera-Saldana, R.E. Gelinas and P.H. Seeburg, The human growth hormone locus: nucleotide sequence, biology, and evolution. Genomics, 4, 479-97 (1989).
12. S.L. Asa, K. Kovacs, F.A. Laszlo, I. Domokos and C. Ezrin, Human fetal adenohypophysis: histologic and immunocytochemical analysis. Neuroendocrinology, 43, 308-316 (1986).
13. J.W. Finkelstein, T.F. Anders, E.J. Sachar, H.P. Roffwarg and L.D. Hellman LD, Behavioural state, sleep stage and growth hormone levels in human infants. J Clin Endocrinol Metab, 32, 368-371 (1971).
14. A. Chatelain, J.P. Dupouy, and M.P. Dubois, Ontogenesis of cells producing polypeptide hormones (ACTH, MSH, LPH, GH, prolactin) in the fetal hypophysis of the rat: influence of the hypothalamus. Cell Tissue Res 196, 409-427 (1979).
15. L.S. Frawley, J.P. Hoeffler and F.R. Boockfor, Functional maturation of somatotropes in fetal rat pituitaries analysis by reverse hemolytic plaque assay. Endocrinology, 116, 2355-2360 (1985).
16. C.A. Birge, G.T. Peake, I.K. Mariz and W.H. Daughaday, Radioimmunoassyable growth hormone in the rat pituitary gland: effects of age, sex and hormonal state. Endocrinology, 81, 195-204 (1967).
17. O.G.P. Isaksson, J-O. Jansson, R.G. Clark and I. Robinson, Significance of the secretory pattern of growth hormone. NIPS, 1, 44-47 (1986).
18. H.K. Choi and D.J. Waxman, Plasma growth hormone pulse activation of hepatic JAK-STAT5 signaling: Developmental regulation and role in male-specific liver gene expression. Growth Horm IGF Res, 141, 3245-3255 (2000).
19. J-O. Jansson, S. Edén and O. Isaksson, Sexual dimorphism in the control of growth hormone secretion. Endocr Rev, 6, 128-150 (1985).
20. S.M. Pincus, E.F. Gevers, I.C. Robinson, G. vanden Berg, F. Roelfsema, M.L. Hartman and J.D. Veldhuis, Females secrete growth hormone with more process irregularity than males in both humans and rats. Am J Physiol, 270, E107-115 (1996).
21. A.W. Heatherington and S.W. Ranson, Hypothalamic lesions and adiposity in the rat. Anat Rec, 78, 149, (1940).
22. S. Reichlin, Growth hormone content of the pituitaries from rats with hypothalamic lesions. Endocrinology, 69, 225-230, (1961).
23. L.A. Frohman, L.L. Bernardis and K.L. Kant, Hypothalamic stimulation of growth hormone secretion. Science, 162, 580-582 (1968).
24. P. Brazeau, W. Vale, R. Burgus, N. Ling, M. Butcher, J. Rivier and R. Guillemin, Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science, 179, 77-79 (1973).
25. L. Pradayrol, H. Jörnvall, V. Mutt and V. Ribet, N-terminally extended somatostatin: the primary structure of somatostatin-28. FEBS Lett, 109, 55-58 (1980).
26. F. Esch, P. Bóhlen, N. Ling, R. Benoit, P. Brazeau and R. Guillemin, Primary structure of ovine hypothalamic somatostatin-28 and somatostatin-25. Proc Natl Acad Sci (USA), 77, 6827-6831 (1980).
27. A.V. Schally, W-Y. Huang, R.C.C. Chang, A. Arimura, T.W. Redding, R.P. Millar, M.W. Hunkapiller and L.E. Hood, Isolation and structure of pro-somatostatin: a putative somatostatin precursor from pig hypothalamus. PNAS, 77, 4489-4493 (1980).
28. H.H. Zingg and Y.C. Patel, Biosynthesis of immunoreactive somatostatin by hypothalamic neurons in culture. J Clin Invest, 70, 1101-1109 (1982).
29. R.A. Steiner, J.K. Stewart, J. Barber, D. Koerker, C.J. Goodner, A. Brown, P. Illner and C.C. Gale, Somatostatin: A physiological role in the regulation of growth hormone secretion in the adolescent male baboon. Endocrinology, 102, 1587-1594 (1978).
30. G.S. Tannenbaum, J. Epelbaum, E. Colle, P. Brazeau and J.B. Martin, Antiserum to somatostatin reverses starvation-induced inhibition of growth hormone but not insulin secretion. Endocrinology, 102, 1909-1914, (1978).
31. K. Ishikawa, Y. Taniguchi, K. Kurosumi, M. Suzuki and M. Shinoda, Immunohistochemical identification of somatostatin-containing neuron projections to the median eminence of the rat. Endocrinology, 121, 94-97 (1987).
32. J.O. Willoughby and J.B. Martin, Pulsatile growth hormone secretion: inhibitory role of medial proptic area. Brain Res, 148, 240-244, (1978).
33. R. Guillemin, P. Brazeau, P. Böhlen, F. Esch, N. Ling and W.B. Wehrenberg, Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science, 218, 585-587 (1982).
34. J. Rivier, J. Spiess, M. Thorner and W. Vale, Characterization of a growth hormone-releasing factor from a human pancreatic islet tumor. Nature, 300, 276-278 (1982).
35. B. Bloch, R.C. Gaillard, P. Brazeau, H.D. Lin and N. Ling, Topographical and ontogenetic study of the neurons producing growth hormone-releasing factor in human hypothalamus. Regul Pept, 8, 21-31, (1984).
36. P.E. Sawchenko, L.W. Swanson, J. Rivier and W.W. Vale, The distribution of growth hormone-releasing factor (GRF) immunoreactivity in the central nervous system of the rat: an immunohistochemical study using antisera directed against rat hypothalamic GRF. J Comp Neurol, 237, 100-115, (1985).
37. J. Spiess, J. Rivier and W. Vale, Characterization of rat hypothalamic growth hormona-releasing factor. Nature, 303, 532-535 (1983).
38. K.E. Mayo, G.M. Cerelli, M.G. Rosenfeld and R.M. Evans, Characterization of cDNA and genomic clones encoding the precursor to rat hypothalamic growth hormone-releasing factor. Nature, 314, 464-467, (1985).
39. P.M. Plotsky and W. Vale, Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophysial-portal circulation of the rat. Science, 230, 461-463, (1985).
40. W. Vale, J. Vaughan, G. Yamamoto, J. Spiess and J. Rivier, Effects of synthetic human pancreatic (tumor) GH releasing factor and somatostatin, triiodothyronine and dexamethasone on GH secretion in vitro. Endocrinology, 112, 1553-1555 (1983).
41. P. Brazeau, N. Ling, F. Esch, P. Bohlen, C. Mougin and G. Guillemin, Somatocrinin (growth hormone releasing factor) in vitro bioactivity; Ca++ involvement, cAMP mediated action and additivity of effect with PGE2. Biochem Biophys Res Commun, 109, 588-594 (1982).
42. P. Zeitler, L. Vician, J.A. Chowen-Breed, J. Argente, G.S. Tannenbaum, D.K. Clifton and R.A. Steiner, Regulation of somatostatin and growth hormone-releasing hormone gene expression in the rat brain. Metabolism, 39, 46-49 (1990).
43. K.A. Burton, E.B. Kabigting, D.K. Clifton and R.A. Steiner, Growth hormone receptor messenger ribonucleic acid distribution in the adult male rat brain and its colocalization in hypothalamic somatostatin neurons. Endocrinology, 131, 958-963 (1992).
44. S. Minami, J. Kamegai, H. Sugihara, N. Suzuki and I. Wakabayashi, Growth hormone inhibits its own secretion by acting on the hypothalamus through its receptors on neuropeptide Y neurons in the arcuate nucleus and somatostatin neurons in the periventricular nucleus. Endocr J, 45, S19-26 (1998).
45. Y.Y. Chan, R.A. Steiner and D.K. Clifton, Regulation of hypothalamic neuropeptide-Y neurons by growth hormone in the rat. Endocrinology, 137, 1319-1325 (1996).
46. J.F. Bazan, Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci (USA), 87, 6934-6938 (1990).
47. J. Finidori and P.A. Kelly, Cytokine receptor signaling through novel families of transducer molecules: Janus kinases and signal transducers and activators of transcription. J Endocrinol, 147, 11-23 (1995).
48. B. Duriez, M.L. Sobrier, P. Duquesnoy, M. Tixier-Boichard, E. Decuypere, G. Coquerelle, M. Zeman, M. Goossens and S. Amselem, A naturally occurring growth hormone receptor mutation: in vivo and in vitro evidence for the functional importance of the WS motif common to all members of the cytokine receptor superfamily. Mol Endocrinol, 7, 806-814 (1993).
49. A.M. DeVos, M. Ultsch and A.A. Kossiakoff, Human growth hormone and the cellular domain of tissue plasminogen activgator at 24-A resolution. Science, 255, 306-312 (1992).
50. M. Murukami, M. Narazaki, M. Hibi, H. Yawata, K. Yasukawa, M. Hamaguchi, T. Taga and T. Kishimoto, Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. Proc Natl Acad Sci (USA), 88, 11349-11353 (1991).
51. K.C. Leung, N. Doyle, M. Ballesteros, M.J. Waters, K.K. Ho, Insulin regulation of human hepatic growth hormone receptors: divergent effects on biosynthesis and surface translocation. J Clin Endocrinol Metab, 85, 4712-4720 (2000).
52. K. He, X. Wang, J. Jiang, R. Guan, K.E. Bernstein, P.P. Sayeski and S.J. Frank, Janus kinase 2 determinants for growth hormone receptor association, surface assembly, and signaling. Mol Endocrinol, 17, 2211-2227 (2003).
53. Y. Zhang, J. Jiang, R.A. Black, G. Baumann and S.J. Frank, Tumor necrosis factor-alpha converting enzyme (TACE) is a growth hormone binding protein (GHBP) sheddase: the metalloprotease (TACE/ADAM-17) is critical for (PMA-induced) GH receptor proteolysis and GHBP generation. Endocrinology, 141, 4342-4348 (2000).
54. W.R. Baumbach, D.L. Horner and J.S. Logan, The growth hormone-binding protein in rat serum is an alternatively spliced form of the rat growth hormone receptor. Genes Dev, 3, 1199-1205 (1989).
55. G. Baumann, Growth hormone binding to a circulating receptor fragment the concept of receptor shedding and receptor splicing. Exp Clin Endocrinol Diabet, 103, 2-6 (1995).
56. J. Gent, P. van Kerkhof, M. Roza, G. Bu and G.J. Strous, Ligand independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis. Proc Natl Acad Sci (USA), 99, 9858-9863 (2002).
57. M.J. Waters, S.W. Rowlinson, R.W. Clarkson, C.M. Chen, P.E. Lobie, G. Norstedt and S. Bastiras, Signal transduction by the growth hormone receptor. Proc Soc Exp Biol Med, 206, 216-220 (1994).
58. J.A. Wells, B.C. Cunningham, G. Fuh, H.B. Lowman, S.H. Bass, M.G. Mulkerrin, M. Ultsch and A.M. deVos, The molecular basis for growth hormone receptor interactions. Rec Prog Horm Res, 48, 253-275 (1993).
59. P.A. Harding, X. Wang, S. Okada, W.Y. Chen, W. Wan and J.J. Kopchick, Growth hormone (GH) and a GH antagonist promote GH receptor dimerization and internalization. J Biol Chem, 271, 6708-6712 (1996).
60. G. Fuh, B.C. Cunningham, R. Fukunaga, S. Nagata, D.V. Goeddel and J.A. Wells, Rational design of potent antagonists to the human growth hormone receptor. Science, 256, 1677-1680 (1992).
61. C. Carter-Su, J. Schwartz and L.S. Smit, Molecular mechanism of growth hormone action. Annu Rev Physiol, 58, 187-20 (1996).
62. T. Zhu, E.L.K. Goh, R. Graichen, L. Ling and P.E. Lobie, Signal transduction via the growth hormone receptor. Cell Signall, 13, 599-616 (2001).
63. L.S. Argetsinger and C. Carter-Su, Mechanism of signaling by growth hormone receptor. Physiol Rev, 76, 1089-1107 (1996).
64. L.S. Argetsinger, G.S. Campbell, X.N. Yang, B.A. Witthuhn, O. Silvennoinen, J.N. Ihle and C. Carter-Su, Identification of Jak2 as a growth hormone receptor associated tyrosine kinase. Cell, 74, 237-244 (1993).
65. P. Colosi, K. Wong, S.R. Leong and W.I. Wood, Mutational analysis of the intracellular domain of the human growth receptor. J Biol Chem, 268, 12617-12623 (1993).
66. H. Dinerstein, F. Lago, L. Goujon, F. Ferrag, N. Exposito, J. Finidori, P.A. Kelly and M.C. Postel-Vinay, The proline-rich region of the GH receptor is essential for Jak2 phosphorylation, activation of cell proliferation and gene transcription. Mol Endocrinol, 9, 1701-1707 (1995).
67. X.Z. Wang, C.J. Darus, B.X.C. Xu and J.J. Kopchick, Identification of growth hormone receptor (GHR) tyrosine residues required for GHR phosphorylation and JAK2 and STATS activation. Mol Endocrinol, 10, 1249-1260 (1996).
68. O. Sivennoinen, J.N. Ihle, J. Schlessinger and D.E. Levy, Interferon-induced nuclear signaling by Jak protein tyrosine kinases. Nature, 366, 583-585 (1993).
69. C. Carter-Su and L.S. Smit, Signaling via Jak tyrosine kinases: growth hormone receptor as a model system. Rec Prog Horm Res, 53, 61-83 (1998).
70. 2+ oscillations and gene transcription. Proc Natl Acad Sci (USA), 92, 2725-2729 (1995).
71. F. Gu, N. Dube, J.W. Kim, A. Cg, Mde. J. Ibarra-Sanchez and Y.R. Tremblay Boisclair, Protein tyrosine phosphatase 1B attenuates growth hormone-mediated JAK2-STAT signalling. Mol Cell Biol, 23, 3753-3762 (2003).
72. L. Goujon, G. Allevato, G. Simonin, L. Paquereau, A. LeCam, J. Clark, J.H. Nielsen, J. Djiane, M.C. Postel-Vinay and M. Edery, Cytoplasmic sequences of the growth hormone receptor necessary for signal transduction. Proc Natl Acad Sci (USA), 91, 957-961 (1994).
73. A. Moldrup, G. Allevato, T. Dyrberg, J.H. Nielsen and N. Billestrup, Growth hormone action in rat insulinoma cells expressing truncated growth hormone receptors. J Biol Chem, 266, 17441-17445 (1991).
74. P.E. Lobie, G. Allevato, J.H. Nielsen, G. Norstedt and N. Billestrup, Requirement of tyrosine residues 333 and 338 of the growth hormone (GH) receptor for selected GH-stimulated function. J Biol Chem, 270, 21745-21750 (1995).
75. B.X.C. Xu, X.Z. Wang, C.J. Darns and J.J. Kopchick, Growth hormone promotes the association of transcription factor STAT5 with the growth hormone receptor. J Biol Chem, 271, 19768-19773 (1996).
76. K.K. Ho, A.J. O'Sullivan and D.M. Hoffman, Metabolic actions of growth hormone in man. Endocr J, 43, S57-S63 (1996).
77. C. Carter-Su, M.M. Ramsey and W.E. Sonntag, A critical analysis of the role of growth hormone and IGF-1 in aging and lifespan. Trends Genet, 18, 295-301 (2002).
78. L.S. Smit, D. Meyer, L. Argetsinger, J. Schwartz and C. Carter-Su, Molecular events in growth hormone receptor interaction and signaling. Handbook of Physiology (vol V)(Kostyo JL ed.) 445-480. Oxford University Press (1999).
79. H. Sakaue, W. Ogawa, M. Takata, S. Kuroda, K. Kotani, H. Matsumoto, H. Sakaue, S. Nishio, H. Ueno and M. Kasuga, Phosphoinositide 3-kinase is required for insulin-induced but not for growth hormone or hyperosmolarity induce glucose uptake in 3T3-L1 adipocytes. Mol Endocrinol, 11, 1552-1562 (1997).
80. M. Ridderstrale and H. Tornqvist, PI-3-kinase inhibitor wortmannin blocks the insulin-like effects of growth hormone in isolated rat adipocytes. Biochem Biophys Res Commun, 203, 306-310 (1994).
81. T. Yamauchi, Y. Kaburagi, K. Ueki, Y. Tsuji, G.R. Stark, I.M. Kerr, T. Tsushima, T. Akanuma, Y. Akanuma, I. Komuro, K. Tobe, Y. Yakazi and T. Kadowaki, Growth hormone and prolactin stimulate tyrosine phosphorylation of insulin receptor substrate-1, -2 and -3, their association with p85 phosphatidylinositol 3-kinase (PI-3kinase) and concomitantly PI-3kinase activation via JAK2 kinase. J Biol Chem, 273, 15719-15726 (1998).
82. L.H. Hansen, B. Madgen, B. Teisner, J.H. Nielssen and N. Billesstrup, Characterization of the inhibitory effect of growth hormone on pituitary preadipocyte differenciation. Mol Endocrinol, 12, 1140-1149 (1998).
83. S.J. MacKenzie, S.J. Yarwood, A.H. Peden, G.B. Bodger, R.G. Vernon and M.D. Houslay, Stimulation of p70S6Kinase via a growth hormone-controlled phosphatidylinositol 3-kinase pathway leads to the activation of a PDE4A cyclic AMP-specific phosphodiesterase in 3T3F442 A preadipocytes. Proc Natl Acad Sci (USA), 95, 3549-3554 (1998).
84. F.P. Dominici, D. Cifone, A. Barthe and D. Turyn, Alterations in the early steps of the insulin-signaling system in skeletal muscle of GH transgenic mice. Am J Physiol, 277, 447-454 (1999).
85. F.P. Dominici, D. Cifone, A. Barthe and D. Turyn, Loss of sensitivity to insulin at early events of the insulin signaling pathway in the liver of growth hormone transgenic mice. J Endocrinol, 161, 383-392 (1999).
86. P-K. Tai, I.F. Liao, E.H. Chen, J.H. Diez, J. Schwartz and C. Carter-Su, Differential regulation of two glucose transporters by chronic growth hormone treatment of cultured T-F442 A adipose cells. J Biol Chem, 265, 21828-21834 (1990).
87. P.D. Gluckman, A.J. Gunn, A. Wray, W.S. Cutfield, P.G. Chatelain, O. Guilbaud, G.R. Ambler, P. Wilton and K. Albertsson-Wikland, Congenital idiopathic growth hormone deficiency associated with prenatal and early postnatal growth failure. The International Board of the Kabi Pharmacia International Growth Study. J Pediatr, 121, 920-923 (1992).
88. P.D. Gluckman and J.E. Harding, Fetal growth retardation: underlying endocrine mechanisms and postnatal consequences. Acta Paediatr, 422, 69-72 (1997).
89. W.D. Salmon Jr and W.H. Daughaday, A hormonally controlled serum factor which stimulates sulphate incorporation by cartilage in vitro. J Lab Clin Med, 49, 825-836 (1957).
90. E. Rinderknecht and R.E. Humbel RE, The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem, 253, 2769-2776 (1978).
91. T.L. Blundell, S. Bedarkar and R.E. Humbel, Tertiary structures, receptor binding and antigenicity of insulin-like growth factors. Fed Proc, 42, 2592-2597 (1983).
92. J. Wang, J. Zhou and C.A. Bondy, Igf1 promotes longitudinal bone growth by insulin-like actions augmenting chondrocyte hypertrophy. FASEB J, 13, 1985-1990 (1999).
93. A.J. DÉrcole, G.T. Applewhite and L.E. Underwood, Evidence that somatomedin is synthesized by multiple tissues in the fetus. Dev Biol, 75, 315-328 (1980).
94. C.T. Roberts Jr, S.R. Lasky, W.L. Lowe Jr, W.T. Seaman and D. LeRoith, Molecular cloning of rat insulin-like growth factor I complementary deoxyribonucleic acids: differential messenger ribonucleic acid processing and regulation by growth hormone in extrahepatic tissues. Mol Endocrinol, 1, 243-248 (1987).
95. V.K. Han, P.K. Lund, D.C. Lee and A.J. D'Ercole, Expression of somatomedin/insulin-like growth factor messenger ribonucleic acids in the human fetus: identification, characterization, and tissue distribution. J Clin Endocrinol Metab, 66, 422-429 (1988).
96. W.L. Lowe Jr, S.R. Lasky, D. LeRoith and C.T. Robertrs Jr, Distribution and regulation of rat insulin-like growth factor 1 messenger ribonucleic acids encoding alternative carboxy-terminal E-peptides: evidence for differential processing and regulation in liver. Mol Endocrinol, 2, 528-535 (1988).
97. O.G. Isaksson, J-O. Jansson and I.A. Gause, Growth hormone stimulates longitudinal bone growth directly. Science, 216, 1237-1239 (1982).
98. A.J. D'Ercole, A.D. Stiles and L.E. Underwood, Tissue concentration of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc Natl Acad Sci (USA), 81, 935-939 (1984).
99. L.A. Perez-Jurado and J. Argente, Molecular basis of familial growth hormone deficiency. Horm Res, 42, 189-197 (1994).
100. A. Bartke, V. Chandrashekar, D. Turyn, R.W. Steger, L. Debeljuk, T.A. Winters, J.A. Mattison, N.A. Danilovich, W. Croson, D.R. Wernsing and J.J. Kopchick, Effects of growth hormone overexpression and growth hormone resistance on neuroendocrine and reproductive functions in transgeneic and knock-out mice. Proc Soc Exp Biol Med, 222, 113-123 (1999).
101. J.J. Jones and D.R. Clemmons, Insulin-like growth factors and their binding proteins biological actions. Endocr Rev, 16, 3-34 (1995).
102. A.J. D'Ercole, P. Ye, A.S. Calikoglu and G. Gutierrez-Ospina, The role of insulin-like growth factors in the central nervous system. Mol Neurobiol, 13, 227-255 (1996).
103. C.A. Bondy and W.H. Lee, Correlation between insulin-like growth factor (IGF)-binding protein 5 and IGF-I gene expression during brain development. J Neurosci, 13, 5092-5104 (1993).
104. W.H. Lee, K.M. Michels and C.A. Bondy, Localization of insulin-like growth factor binding protein-2 messenger RNA during postnatal brain development: correlation with insulin-like growth factors I and II. Neuroscience, 53, 251-263 (1993).
105. V.C. Russo, S.R. Edmondson, F.A. Mercuri, C.R. Buchanan and G.A. Werther, Identification, localization, and regulation of insulin-like growth factor binding proteins and their messenger ribonucleic acids in the newborn rat olfactory bulb. Endocrinology, 135, 1437-1446 (1994).
106. G. A. Werther, M. Abate, A. Hogg, H. Cheesman, B. Oldfield, D. Hards, P. Hudson, B. Power, K. Freed and A.C. Herington, Localization of insulin-like growth factor-I mRNA in rat brain by in situ hybridization-relationship to IGF-I receptors. Mol Endocrinol, 4, 773-778 (1990).
107. A. Grimberg and P. Cohen, Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol, 183, 1-9 (2000).
108. R. Baserga, The contradictions of the insulin-like growth factor I receptor. Oncogene, 19, 5574-5581 (2000).
109. B. Valentinis and R. Baserga, IGF-I receptor signaling in transformation and differentiation. Mol Pathol, 54, 133-137 (2001).
110. F. Peruzzi, M. Prisco, M. Dews, P. Salamoni, E. Grasilli, G. Romano, B. Calabretta and R. Baserga, Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection of apoptosis. Mol Cell Biol, 19, 7203-7215 (1999).
111. H. Yu and T.J. Rohan, Role of the insulin-like growth factor family in cancer development and progression. Natl Cancer Inst, 92, 1472-1489 (2000).
112. R. Baserga, A. Hongo, M. Rubini, M. Prisco and B. Valentini, The IGF-I receptor in cell growth, transformation and apoptosis. Biochem Biophys Res Commun, 214, 475-481 (1995).
113. C. D'Ambrosio, A. Ferber, M. Resnicoff and R. Baserga, A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis. Cancer Res, 56, 4013-4020 (1996).
114. G. Romano, K. Reiss, X. Tu, F. Peruzzi, B. Belleti, J.Y. Wang, T. Zanocco Maranni and R. Baserga, Efficient in vitro and in vivo gene regulation of a retrovirally-delivered pro-apoptotic factor under the control of the Drosophila HSP70 promoter. Gene Ther, 8, 600-607 (2001).
115. K. Reiss, X. Tu, G. Romano, F. Peruzzi, Y. Kanes and R. Baserga, Intracellular association of a mutant insulin-like growth factor receptor with endogenous receptors. Clin Cancer Res, 7, 2134-2144 (2001).
116. J.R. Florini, D.Z. Ewton, S.L. Falen and J.J. Van Wyk, Biphasic concentration dependency of stimulation of myoblast differenciation. Am J Physiol, 250, 771-778 (1986).
117. P.J. Schmid, T. Steiner and E.R. Froesch, Preferential enhancement of myoblast differentiation by insulin-like factors (IGF-I and IGF-II) in primary cultures of chicken embryonic cells. FEBS Lett, 161, 117-121 (1983).
118. P.J. Smith, L.S. Wise, R. Berkovitz, C. Wan and C.S. Rubin, Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. J Biol Chem, 263, 9402-9408 (1988).
119. M. Lorenzo, A.M. Valverde, T. Teruel and M. Benito, IGF-I is a mitogen involved in differentiation-related gene expression in fetal rat brown adipocytes. J Cell Biol, 123, 1567-1575 (1993).
120. P.J. Schmid, T. Steiner and E.R. Froesch, Insulin-like growth factor-I supports differentiation of cultured osteoblast-like cells. FEBS Lett, 173, 48-52 (1984).
121. F.A. McMorris, T.M. Smith, S. DeSalvo and R.W. Furlanetto, Insulin-like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development. Proc Natl Acad Sci (USA), 83, 822-826 (1986).
122. J.F. Mill, M.V. Chao and D.N. Ishii, Insulin, Insulin-like growth factor-II and nerve growth effects on tubulin mRNA levels and neurite formation. Proc Natl Acad Sci (USA), 81, 7126-7130 (1985).
123. E. Recio-Pinto, F.F. Lanf and D.N. Ishii, Insulin and insulin-like growth factor II permit nerve growth factor binding and the neurite response in human cultured neuroblastoma cells. Proc Natl Acad Sci (USA), 81, 2562-2566 (1984).
124. A. Morrione, G. Romano, M. Navarro, K. Reiss, B. Valentinis, M. Dews, E. Eves, M.R. Rosner and R. Baserga, Insulin-like growth factor I receptor signaling in differentiation of neuronal H19-7 cells. Cancer Res, 60, 2263-2272 (2000).
125. A. Morrione, M. Navarro, G. Romano, M. Dews, K. Reiss, B. Valentinis, B. Belletti and R. Baserga, The role of the insulin receptor substrate-1 in the differentiation of rat hippocampal neuronal cells. Oncogene, 20, 4842-4852 (2001).
126. M. Valtieri, D.J. Tweardy, D. Caracciolo, K. Johnson, F. Mavilio, S. Altmann, D. Santoli and G. Rovera, Cytokine-dependent granulocytic differentiation. Regulation of proliferative and differentiative responses in a murine progenitor cell line. J Immnunol, 138, 3829-2835 (1987).
127. B. Cristofanelli, B. Vallentinis, S. Soddu, M.G. Rizzo, A. Marchetti, G. Bossi, A.R. Morena, M. Dews, R. Baserga and A. Sacchi, Cooperative transformation of 32D cells by the combined expression of IRS-1 and V-Ha-Ras. Oncogene, 19, 3245-3255 (2000).
128. B. Valentinis, M. Navarro, T. Zanocco-Marani, P. Edmons, J. McCormick, A. Morrione, A. Sacchi, G. Romano, K. Reiss and R. Baserga, Insulin-receptor substrate-1, p70S6K, and cell size in transformation and differentiation of hemopoietic cells. J Biol Chem, 275, 25451-25459 (2000).
129. B. Valentinis, G. Romano, F. Peruzzi, A. Morrione, M. Prisco, S. Soddu, B. Cristofanelli, A. Sacchi and R. Baserga, Growth and differentiation signals by the insulin-like growth factor I receptor in hemopoietic cells are mediated through different pathways. J Biol Chem, 274, 12423-12430 (1999).
130. K. Reiss, J.Y. Wang, G. Romano, X. Tu, F. Peruzzi and R. Baserga, Mechanisms of regulation of cell adhesion and motility by insulin receptor substrate-1 in prostate cells. Oncogene, 20, 490-500 (2001).
131. M. Navarro and R. Baserga, Limited redundancy of survival signals from the type 1-insulin-like growth factor receptor. Endocrinology, 142, 1073-1081 (2001).
132. N.J. Mc Carthy, M.K.B. Whyte, C.S. Gilbert and G.I. Evan, Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage or the Bcl-2 homologue Bak. J Cell Biol, 136, 215-227 (1997).
133. M.G. Myers, T.C. Grammer, L.M. Wang, X.J. Sun, J.H. Pierce, J. Blenis and M.F. White, Insulin receptor substrate-1 mediates phosphatidylinositol 3kinase and p70S6k signaling during insulin, insulin like growth factor 1 and interleukin-4 stimulation. J Biol Chem, 269, 28783-28789 (1994).
134. J.S. Greenberger, M.A. Sakakeeny, C.J. Humphries, C.J. Eaves and R.J. Eckner, Demonstration of permanent factor-dependent multipotential erythroid/neutrophil/basophil hemopoietic progenitor cell lines. Proc Natl Acad Sci (USA), 80, 2931-2935 (1983).
135. G.J. Pronk, J. McGlade, G. Pelicci, T. Pawson and J.L. Bos, Insulin-induced phosphorylation of the 46-and 52-kDa She proteins. J Biol Chem, 268, 5748-5753 (1993).
136. T. Sasaoka, D.W. Rose, B.H. Jhun, A.R. Saltier, B. Draznin and J.M. Olefsky, Evidence for a functional role of She proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1 and epidermal growth factor. J Biol Chem, 269, 13689-13694 (1994).
137. S.M. Twigg, M.C. Kiefer, J. Zapf and R.C. Baxter RC, Insulin-like growth factor-binding protein 5 complexes with the acid-labile subunit. Role of the carboxyl-terminal domain. J Biol Chem, 273, 28791-28798 (1998).
138. L.J. Cobb, D.A. Salih, I. Gonzalez, G. Tripathi, E.J. Carter, F. Lovett, C. Holding and J.M. Pell, Partitioning of IGFBP-5 actions in myogenesis: IGF-independent anti-apoptotic function J Cell Sci, 117, 1737-1746 (2004).
139. S. Mohan and D.J. Baylink, IGF-binding proteins are multifunctional and act via IGF-dependent and independent mechanisms. J Endocrinol, 175, 19-31 (2002).
140. C. Lassarre, S. Hardouin, F. Daffos, F. Forestier, F. Frankeene and M. Binoux, Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr Res, 29, 219-225 (1991).
141. R.I. Holt, Fetal programming of the growth hormone-insulin- like growth factor axis. Trends Endocrinol Metab. 13, 392-397 (2002).
142. P.D. Gluckman, J.H. Butler, R. Comline and A. Fowden, The effects of pancreatectomy on the plasma concentrations of insulin-like growth factors 1 and 2 in the sheep fetus. J Dev Physiol, 9, 79-88 (1987).
143. M. Gourmelen, Y. Le Bouc, F. Girard and M. Binoux, Serum levels of insulin-like growth factor (IGF) and IGF binding protein in constitutionally tall children and adolescents. J Clin Endocrinol Metab, 59, 1197-1203 (1984).